GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FVCB · Jun 30, 2025

FVCBankcorp, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001675644-25-000126Bank
Sequential deposit growth40thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-0.17% · CORE · VALID

Net-income growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

36.39% · CORE · VALID

Interest-income growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

5.21% · CORE · VALID

Cash and equivalents60thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$14.6M · CORE · VALID

Sequential loan growth25thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

-0.68% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History32 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
1.93%
Current
-0.17%
Delta
-2.09%
Earnings Growth Decreased
Previous
285.45%
Current
36.39%
Delta
-249.06%
Interest Income Growth Decreased
Previous
6.45%
Current
5.21%
Delta
-1.24%
Liquidity Increased
Previous
$13.0M
Current
$14.6M
Delta
$1.7M
Loan Growth Decreased
Previous
0.63%
Current
-0.68%
Delta
-1.31%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.